v3.26.1
Condensed Consolidated Interim Statements of Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Expenses    
General and administrative $ 2,147 $ 2,244
Demonstration Plant operations 1,306 855
Management and directors' fees 531 477
Share-based compensation 1,265 1,420
Separation benefits 0 100
Other 6 6
Foreign exchange (gain) loss (2,221) 2
Loss from operations 3,034 5,104
Investment loss from Smackover Lithium (1,502) (984)
Fair value (loss) gain on financial asset - FID (836) 741
Fair value gain on Investment in Aqualung 91 2,990
Interest and other income 1,273 250
Interest expense (4) (10)
Net loss before income taxes (4,012) (2,117)
Deferred income tax benefit 1,274 567
Net loss (2,738) (1,550)
Item that may be reclassified subsequently to income or loss:    
Currency translation differences of foreign operations (2,354) 20
Total comprehensive loss $ (5,092) $ (1,530)
Weighted average number of common shares outstanding - Basic 241,690,043 192,568,062
Weighted average number of common shares outstanding - Diluted 241,690,043 192,568,062
Basic loss per share (in USD per share) $ (0.01) $ (0.01)
Diluted loss per share (in USD per share) $ (0.01) $ (0.01)